Hyaluronic Acid Market By Source (Animal-Based Hyaluronic Acid, Biofermentation-Based Hyaluronic Acid, Plant-Based Hyaluronic Acid), By Application (Dermal Fillers, Joint Health and Osteoarthritis Treatment, Skin Care and Cosmetics, Ophthalmic Surgery, Wound Healing), By End-Use Industry (Pharmaceuticals, Cosmetics and Personal Care, Healthcare, Food and Beverages, Veterinary), By Form (Powder, Liquid, Gel), and By Region; Global Insights & Forecast (2023 ? 2030)

As per Intent Market Research, the Hyaluronic Acid Market was valued at USD 9.9 billion in 2024-e and will surpass USD 15.8 billion by 2030; growing at a CAGR of 8.1% during 2025 - 2030.

The hyaluronic acid market has witnessed significant growth over the past few years, driven by its diverse applications across industries such as healthcare, cosmetics, pharmaceuticals, and food. Known for its ability to retain moisture and its natural occurrence in the human body, hyaluronic acid is widely used in dermal fillers, joint health treatments, wound healing, and skincare products. The increasing awareness of its benefits, coupled with the rising demand for non-invasive treatments in aesthetics and the growing aging population, is driving this market's expansion. As new applications continue to emerge, particularly in the medical and cosmetic sectors, the market is expected to grow further in the coming years.

Animal-Based Hyaluronic Acid Is Largest Owing To Its Established Application in Cosmetics and Healthcare

Animal-based hyaluronic acid remains the largest segment in the market, primarily due to its long-established use in dermal fillers, joint health treatments, and cosmetic applications. This form of hyaluronic acid, typically derived from rooster combs, has been widely recognized for its high molecular weight and its ability to retain moisture, which makes it ideal for skin hydration and wrinkle reduction. The well-established production processes for animal-based hyaluronic acid have made it a preferred choice for various applications, particularly in the cosmetics industry for anti-aging and skin rejuvenation treatments.

Moreover, animal-based hyaluronic acid continues to dominate the healthcare segment, especially for joint health treatments, as it plays a critical role in reducing pain and improving mobility in patients suffering from osteoarthritis. It is commonly used in viscosupplementation therapy, where injections of hyaluronic acid are administered into the joints to restore the natural viscosity of the synovial fluid, providing relief from arthritis symptoms. As consumer demand for both aesthetic and medical applications increases, this segment is expected to retain its market leadership.

Dermal Fillers Are the Fastest Growing Application Due to Rising Demand for Non-Invasive Cosmetic Procedures

Among the various applications of hyaluronic acid, dermal fillers are experiencing the fastest growth. The demand for non-invasive cosmetic procedures, such as wrinkle reduction, lip enhancement, and facial contouring, has surged in recent years, particularly in developed regions such as North America and Europe. Hyaluronic acid-based dermal fillers are preferred because they provide immediate results, require minimal downtime, and are generally considered safe with a low risk of allergic reactions.

The increasing popularity of aesthetic treatments, combined with a growing desire for facial rejuvenation and anti-aging solutions, has driven the growth of this application. With the rise of social media influencers and the increasing acceptance of cosmetic treatments across various age groups, dermal fillers are expected to see continued growth. Additionally, innovations in hyaluronic acid formulations, such as longer-lasting fillers and products with improved viscosity, are further contributing to the expansion of this market segment.

Cosmetics and Personal Care Is Largest End-Use Industry Owing to Growing Consumer Demand for Anti-Aging Products

The cosmetics and personal care industry is the largest end-use segment for hyaluronic acid, driven by the growing consumer demand for anti-aging skincare products. Hyaluronic acid is widely used in moisturizers, serums, facial masks, and other skincare formulations due to its ability to retain moisture and improve skin elasticity. As consumers become more aware of the benefits of hyaluronic acid for maintaining youthful, hydrated skin, its demand in the cosmetic sector has surged.

In addition to its anti-aging benefits, hyaluronic acid is also valued for its soothing properties, making it a popular ingredient in products designed for sensitive skin. It is often used to treat conditions such as eczema and dry skin, further boosting its use in the cosmetics industry. As skincare products with hyaluronic acid continue to evolve, incorporating advanced formulations and delivery methods, this segment is expected to see sustained growth.

Gel Form Is Fastest Growing Due to Increased Demand for Injectable Treatments

Among the various forms of hyaluronic acid, the gel form is experiencing the fastest growth, primarily due to its increasing use in injectable treatments such as dermal fillers. Hyaluronic acid gels are preferred for their ability to be easily injected into specific areas of the face or body, providing immediate, long-lasting results for wrinkle reduction, volume restoration, and facial contouring. The formulation of hyaluronic acid into gel form allows for more precise application, making it ideal for aesthetic treatments that require high accuracy and minimal discomfort.

Furthermore, the growing popularity of non-surgical cosmetic procedures, which offer minimal recovery time and natural-looking results, has contributed significantly to the demand for gel-based hyaluronic acid products. As the technology behind injectable treatments advances, including the development of more stable and longer-lasting formulations, the gel form is expected to dominate the market in the coming years.

North America Is Largest Region Owing to High Demand for Aesthetic Treatments and Healthcare Solutions

North America remains the largest region in the global hyaluronic acid market, driven by high demand for aesthetic treatments and healthcare solutions. The region’s mature healthcare infrastructure, along with high disposable income, has made it a hub for advanced cosmetic procedures, including dermal fillers and joint health treatments. In addition, the growing awareness of the benefits of hyaluronic acid in skincare and its widespread use in anti-aging products has fueled its demand in North America.

The presence of key players in the market, such as Allergan and Galderma, further strengthens the region's dominance. Moreover, the aging population in North America is also contributing to the increased use of hyaluronic acid in joint health treatments, particularly for osteoarthritis. As the region continues to lead in both the medical and cosmetic applications of hyaluronic acid, North America is poised to maintain its position as the largest market.

Leading Companies and Competitive Landscape

The hyaluronic acid market is highly competitive, with several global players dominating the landscape. Companies such as Allergan, Galderma, Merz Pharmaceuticals, and Shiseido lead the market due to their strong portfolios of hyaluronic acid-based products, particularly in dermal fillers and skincare formulations. These companies are investing heavily in research and development to innovate new products with improved efficacy and longer-lasting effects.

The competitive landscape is characterized by strategic partnerships, acquisitions, and product launches aimed at strengthening market positions. For example, Allergan's acquisition of Anteis Laboratories allowed the company to expand its dermal filler offerings, while Merz Pharmaceuticals continues to innovate with its Belotero range of injectable hyaluronic acid products. With increasing demand across both cosmetic and healthcare applications, these companies are well-positioned to capitalize on the growing market opportunities.

Recent Developments:

• Allergan announced the acquisition of Anteis Laboratories, a leader in hyaluronic acid-based dermal fillers, enhancing its portfolio of aesthetic treatments.
• Galderma launched Restylane Kysse, a new hyaluronic acid-based dermal filler designed for lip enhancement, using advanced cross-linking technology for long-lasting results.
• Merz Pharmaceuticals expanded its hyaluronic acid production capabilities by opening a new plant in Europe to meet the growing demand for injectable treatments.
• Ferring Pharmaceuticals received FDA approval for a new hyaluronic acid injection to treat knee osteoarthritis, offering a non-surgical option for pain relief.
• Shiseido announced a partnership with Bloomage Biotechnology to co-develop a new line of skincare products featuring hyaluronic acid as a key ingredient for deep skin hydration.

List of Leading Companies:

• Allergan PLC
• Sanofi S.A.
• Revance Therapeutics, Inc.
• Galderma S.A.
• Merz Pharmaceuticals
• LG Chem
• Shiseido Company, Limited
• Hyaltech Ltd.
• Janssen Pharmaceuticals
• Seikagaku Corporation
• Hyaluronic Acid Company
• Ferring Pharmaceuticals
• Kewpie Corporation
• Bloomage Biotechnology Corporation Limited
• Samsung Biologics

Report Scope: